High fluorescence intensity nanoparticles were prepared by copolymerization of Eu(TTA) 3 Phen doped styrene and methyl methacrylate. The fluorescent nanoparticles were used as labels for the quantitative detection of serum pepsinogens. Anti-pepsinogen I antibodies and anti-pepsinogen II antibodies were coated on the nitrocellulose membrane as test line 1 and test line 2 respectively. Serum pepsinogen I and pepsinogen II were detected simultaneously in one strip through sandwich immunoassay. This immunoassay strip can analyze the serum pepsinogens in one step and obtain results within 15 minutes.
Introduction
Fluorescent nanoparticles have been widely used in the eld of biological and medical applications. Such nanoparticles provide a new method for the detection of related medical and biological markers due to their stability and high-yield properties. In the past years, europium complex doped polymers as nano-bers and nanoparticles were widely researched [1] [2] [3] [4] [5] [6] and it is known that europium complex doped poly(methyl methacrylate) (PMMA) and europium complex doped polystyrene (PS) show a high uorescence intensity and thermal stability.
3-6
Europium complex doped latex nanoparticles are increasingly applied in clinical applications such as cellular and molecular imaging and immunodetection because of their relatively low cytotoxicity and good biocompatibility. 7 In this work, we found that europium complex doped copolymerization of PMMA and PS had stronger uorescence intensity than single polymerization. The effect on the uorescence intensity and the relationship between the styrene ratio and the methyl methacrylate ratio were investigated.
Pepsinogen (PG) includes pepsinogen I (PG I) and pepsinogen II (PG II), is a prognostic marker in gastrointestinal disease. 8 Alteration of serum pepsinogen concentrations has been found to associate with diseases such as Helicobacter pylori infection, peptic ulcer disease, gastritis, and gastric cancer.
8-12
Quantitative detection of serum PG I and PG II concentrations can be used as means for monitoring the gastric diseases. To date, numerous analytical methods have been used in the detection of PG concentrations such as radioimmunoassay (RIA), enzyme-linked immunosorbent assay (ELISA) and time-resolved uoroimmunoassay (TRFIA).
13,14 Most of these methods need 2 to 3 hours of incubation and require professional operations. Gastroscopy is the golden standard for gastric disease detection, but it is painful and expensive for patients. Lateral ow immunochromatographic assay (LFIA) have been widely used in detection of medical and biological markers for being convenient, highly efficient, and relatively low cost. 15, 16 For these reasons, we have developed a rapid and low cost method for the detection of pepsinogen based on LFIA and high uorescent intensity nanoparticles.
In this paper, we prepared high uorescence intensity nanoparticles with europium complexes doped copolymerization of PMMA and PS. Carboxyl-functionalized polyvinyl alcohol (PVA) was used as dispersion agents and it provided a long chain carboxyl group. The synthesized nanoparticles were used as uorescent tags for the detection of serum pepsinogen. Based on LFIA, PG I and PG II were quantitatively analyzed.
Materials and methods

Materials
Europium(III) chloride hexahydrate (EuCl 3 $6H 2 O), 2-thenoyltriuoroacetone (TTA), 1,10-phenanthroline (Phen), poly(vinyl alcohol) (PVA, MW ¼ 9000-10 000), N,N-dimethylformamide (DMF), succinic anhydride, styrene (St), methyl methacrylate (MMA), potassium persulfate (KPS), 2-(N-morpholino) ethanesulfonic acid (MES), and D-(+)-glucose were purchased from Sigma-Aldrich (Shanghai, China 
Synthesis of Eu(TTA) 3 Phen
Eu(TTA) 3 Phen was prepared according to a reported method. Briey, 0.73 g of EuCl 3 $6H 2 O salt (2 mmol) was dissolved in 20 mL of ethanol in ask. TTA (6 mmol) and Phen (2 mmol) were dissolved in 20 mL of ethanol in another ask. The EuCl 3 $6H 2 O salt solution was slowly dropped into the TTA and Phen solution with continuous stirring. The pH value of the solution was adjusted to 7. Then the solution reacted at room temperature for 2 hours. The precipitate produced was washed by ethanol and centrifuged three times at 10 000g. The product formed is dried for 12 hours at 60 C in oven.
PVA functionalization
Carboxyl-functionalized PVA was prepared according to the method reported by Stipniece.
17 Briey, 7 g of PVA (MW ¼ 9000-10 000) was dissolved in 100 mL of DMF in ask at 120 C using an oil bath. The solution was cooled to 60 C and 3.2 g of succinic anhydride was added and reacted at the same temperature for 20 hours. The product was cooled to room temperature and poured into 300 mL of cooled ethyl acetate. The precipitate was washed with ethyl acetate twice and dissolved in 100 mL methanol. The solution was further precipitated by adding 200 mL diethyl ether and separated by centrifugation. The product was washed with diethyl ether. Diethyl ether was removed under reduced pressure and the succinate-modied PVA (M-PVA) was dried at 37 C in oven.
Preparation of carboxyl-functionalized uorescent nanoparticle
Eu(TTA) 3 Phen was dissolved in styrene (St) and methyl methacrylate (MMA) mixture at concentration of 1% using ultrasound. 0.1 g M-PVA and 0.1 g sodium bicarbonate was dissolved in 200 mL deionized water in a three-neck roundbottom ask to form an aqueous phase. The miniemulsion was made by adding the Eu(TTA) 3 Phen solution to the aqueous phase followed by 15 minutes of ultrasound treatment. The miniemulsion was deoxygenated under nitrogen for 30 min and heated to 80 C with magnetical stirring. Then 8 mL of 1% potassium persulfate (KPS) in deionized water was added to the reaction mixture and reacted for 12 hours. The uorescent nanoparticles were puried by ltration and centrifugation and then washed with deionized water containing 0.05% Tween-20.
Conjugation of uorescent nanoparticles with antipepsinogen antibodies
Anti-pepsinogen antibodies were conjugated to carboxylfunctionalized uorescent nanoparticles via an amide bond. 5 mg of the uorescent nanoparticles were mixed with 2 mM NHS and 5 mM EDC in MES buffer (pH 4.7) and incubated for 30 min at 37 C. Aer washing and centrifugation, the uores-cent nanoparticles were dispersed in 50 mM borate buffer (pH 8.5). Then 0.1 mg of anti-pepsinogen I antibodies and antipepsinogen II antibodies were added to 2.5 mg uorescent nanoparticles individually. The solution was incubated for 3 h at 37 C. Residual nonspecic binding sites were blocked by BSA solution to a nal concentration of 5% and incubated for 30 min at 37 C. At last, the conjugates were puried by centrifugation. The product was washed 3 times and stored at 4 C.
Preparation of pepsinogen immunoassay strips
In order to prepare the pepsinogen immunoassay strips, antipepsinogen I coating antibodies and anti-pepsinogen II coating antibodies were dispensed onto the nitrocellulose membrane at 1.8 mg mL À1 as the test line 1 and test line 2 respectively. The goat anti-mouse IgG antibodies were dispensed onto the nitrocellulose membrane at 0.6 mg mL À1 as the control line. The conjugated uorescent nanoparticles of anti-pepsinogen I antibodies and anti-pepsinogen II antibodies were mixed and dispensed at a ratio of 15 mL cm À1 onto the sample pad. The antibodies and conjugates were dispensed using the XYZ3050 dispensing system (BioDot Inc, Irvine, CA) and then dried at 37 C for 4 h in a vacuum oven. The pepsinogen immunoassay strip was assembled in its standard conguration as shown in Fig. 1c .
Detection of pepsinogen antigens by pepsinogen immunoassay strips
Human pepsinogen I protein and human pepsinogen II protein were used as standard analytes, which were purchased from Fitzgerald Company. PG I and PG II protein were diluted to 0, 0.5, 1, 5, 10, 50, 100, 500 ng mL À1 with newborn bovine serum respectively. Sixty microliters of the analytes were added to the end of sample pad of the pepsinogen immunoassay strips. The uorescence signals of test line 1, test line 2 and control line were scanned by a uorescence test strip scanning device at 15 min aer the addition of analytes. Since the uorescent nanoparticles conjugated PG I or PG II antibodies bound specically to PG I or PG II protein and were captured at the test line 1 or test line 2 to form a sandwich complex, the uores-cence intensity was correlated with the sensitivity of the immunoassay.
Results and discussion
Properties of Eu(TTA) 3 Phen
The Eu(TTA) 3 Phen complex were dissolved in DMSO, UV-visible absorption and uorescence spectra was measured. As shown in Fig. 2a , the maximum absorption peak of Eu(TTA) 3 Phen in DMSO solution was at 272 nm and 346 nm which was attributed to the absorption of ligands TTA and Phen. In Fig. 2b , emission spectra of Eu(TTA) 3 Phen were detected by uorescence spectrometer (Thermo scientic LUMINA). The maximum emission 
Properties of the uorescent nanoparticles
The copolymerization of Eu(TTA) 3 Phen doped styrene and methyl methacrylate uorescent nanoparticles (EU-PS-PMMA) was prepared with different monomer ratio of St and MMA. The dynamic light scattering analysis and uorescence intensity in Table 1 shows the monomer ratio of St and MMA has signicant inuence on the uorescence intensity and particle size. Higher the St monomer ratio, larger the size of the nanoparticles, but weaker the uorescence intensity. Higher the MMA monomer ratio, smaller the particle size but stronger the uorescence intensity. When the ratio of St to MMA is 3 to 3, the uorescence intensity is maximum. Further alteration in the ratio results in a decrease in the uorescence intensity. Fig. 3 shows the uo-rescence spectra for different monomer ratios. In Fig. 4a , FT-IR spectroscopy shows the characteristic frequencies of copolymerization of styrene and methyl methacrylate. The morphology and size of EU-PS-PMMA nanoparticles were characterized by TEM, which indicates that particles are uniform and nearly monodisperse.
The stability of uorescence intensity of EU-PS-PMMA nanoparticles in acidic-to-alkaline pH environment was measured. EU-PS-PMMA nanoparticles were dispersed in pH 1-13 water (adjusted by HCl or NaOH), and the uorescence intensity was detected by uorescence spectrometry at different time and relative intensity was calculated. Fig. 5 shows that at pH 3-13 , the uorescence intensity changed less than ten percent in 48 hours which suggest that EU-PS-PMMA nanoparticles were stable especially at weak alkaline environment. At pH 1, EU-PS-PMMA nanoparticles was aggregated and uorescence intensity was declined by 27% suddenly and decreased less than ten percent with increasing time. As we known Eu(TTA) 3 Phen was unstable in acidic and alkaline environments therefore Eu(TTA) 3 Phen was coated inside the nanoparticles through self-assembly with St and MMA.
Detection of pepsinogen immunoassay strips
We used EU-PS-PMMA uorescent nanoparticles with monomer ratio at 3 to 3 as uorescent probes of pepsinogen immunoassay strips. The highest uorescence intensity and carboxylfunctionalized PVA make the labeled probes highly efficient. We detected PG I and PG II protein diluted at 0, 0.5, 1, 5, 10, 50, 100, 500 ng mL À1 with newborn bovine serum respectively. The uorescence intensity of pepsinogen immunoassay strip was scanned using a uorescence test strip scanner. The signals of test line 1, test line 2 and control line were recorded and a relative intensity of T 1 /C and T 2 /C was calculated. When the high concentration samples tested, the conjugated uorescent nanoparticles bound to the test line is more while bound to the control line is less. And the ratio of T/C concentration difference is greater that of test line. As show in Fig. 6 , a standard curve was constructed by plotting T 1 /C, T 2 /C relative intensity and PG I, PG II concentration. It shows that the mathematical relationship between T 1 /C relative intensity and PG I concentration has a correlation coefficient of 0.9992 and the mathematical relationship between T 2 /C relative intensity and PG II concentration has a correlation coefficient of 0.9996. To evaluate the limit of detection (LOD) of pepsinogen immunoassay strips, a cutoff value, which is the average of the T/C relative intensity plus three times of its standard deviations, was calculated by detecting y blank samples. The cutoff value for both PG I and PG II was 0.031. PG I and PG II concentration of 0.5 ng mL À1 or higher could be detected by pepsinogen immunoassay strips, thus the LOD was 0.5 ng mL À1 for standard analytes detection. The relative standard deviations (RSD) and recovery rates were later calculated accordingly. Table 2 shows the RSD results and recovery rates. For high concentration samples, the RSD were less than 10% and the recovery rates were within 93.0-108.2%. For low concentration samples, the RSD were higher than 10% and the recovery rates were relatively low. This was because the human serum contains a certain concentration of PG I and PG II protein, when adding low concentration samples, the detection difference was larger. Generally, the pepsinogen immunoassay strips had good reproducibility and the test results were accurate and reliable. Quantitative detection of serum pepsinogen have signicant value in screening for gastric cancer and precancerous lesion, and other gastric diseases. [19] [20] [21] [22] As preliminary screening method, pepsinogen immunoassay strips can rapidly analyze the sample within 15 min. Compared with chemiluminescent immunoassays, the detection limits are basically the same but the relative standard deviations and range of % differences in measured results are higher than chemiluminescent method.
22
The accuracy of solid phase reaction is lower than that of liquid phase reaction, but its rapid and simple operation can be used as a supplement to the precise and quantitative detection.
Conclusions
High uorescence intensity EU-PS-PMMA nanoparticles were prepared via self-assembly. The monomer ratio of St and MMA has signicant inuence on the uorescence intensity and particle size. EU-PS-PMMA uorescent nanoparticles based pepsinogen immunoassay strips can rapidly analyze the serum sample through one step and the results were objectively analyzed within 15 min. The LOD of this pepsinogen immunoassay strips for PG I and PG II standard analytes was 0.5 ng mL À1 . The dynamic concentration range of PG I and PG II was from 0.5 to 500 ng mL À1 . The reproducibility and recovery tests
show that the quantitative results were accurate. The high accuracy and rate for the determination of serum PG I and PG II suggest that this can be used as a supplement method in clinical applications. 
